Published in Hospital Business Week, September 14th, 2008
For the 2008 third quarter, Angeion announced net income of $259,000, or $0.06 per diluted share, on revenues of $7.6 million. This compares to 2007 third quarter net income of $4,000, or $0.00 per diluted share, on revenues of $8.9 million. Angeion's 2008 third quarter revenues were $1.3 million lower than the prior year due to the previously announced conclusion of a customer's nonrecurring clinical trial program, as well as a general year-over-year softening of orders in the Company's domestic capital equipment business.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hospital Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.